Novelties in Diffuse Large B-cell Lymphoma at ASH2025

Professor Amanda Psyrri summarizes the most important practice-changing trial results, emerging biomarker data, and therapeutic advances in head and neck cancer presented at the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:head-and-neck-cancer-highlights-esmo-2…

Doctor Kohei Shitara highlights key advances in clinical practice, evolving therapeutic strategies, and patient care management in gastroesophageal cancer at the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:advancing-clinical-practice-and-patient-care-gastroeso…

Professor Ferdinandos Skoulidis presents the landmark Phase III KRASCENDO-1 study results evaluating the efficacy and safety of divarasib versus standard-of-care sotorasib or adagrasib in previously treated locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer (NSCLC) at the E…

Professor Kohei Shitara discusses key findings from two pivotal late-breaking trials in gastroesophageal cancer presented at the ESMO Congress 2026: the HERIZON-GEA-01 study and the CLARITY-Gastric 01 trial. Video: https://medicaldigest.org/scientific-contents/interview:key-clinical-updates-gastroe…